Pooled multicenter analysis of cardiovascular safety and population pharmacokinetic properties of piperaquine in African patients with uncomplicated falciparum Malaria

Pooled multicenter analysis of cardiovascular safety and population pharmacokinetic properties of piperaquine in African patients with uncomplicated falciparum Malaria

Dihydroartemisinin-piperaquine has shown excellent efficacy and tolerability in malaria treatment. However, concerns have been raised of potentially harmful cardiotoxic effects associated with piperaquine. The population pharmacokinetics and cardiac effects of piperaquine were evaluated in 1,000 pat...

Bibliografske podrobnosti
Main Authors:	Wattanakul, T, Ogutu, B, Kabanywanyi, AM, Asante, K-P, Oduro, A, Adjei, A, Sie, A, Sevene, E, Macete, E, Compaore, G, Valea, I, Osei, I, Winterberg, M, Gyapong, M, Adjuik, M, Abdulla, S, Owusu-Agyei, S, White, NJ, Day, NPJ, Tinto, H, Baiden, R, Binka, F, Tarning, J
Format:	Journal article
Jezik:	English
Izdano:	American Society for Microbiology 2020

Podobne knjige/članki

Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms.
od: Abdunoor M Kabanywanyi, et al.
Izdano: (2016-01-01)

Post-licensure safety evaluation of dihydroartemisinin piperaquine in the three major ecological zones across Ghana.
od: Abraham R Oduro, et al.
Izdano: (2017-01-01)

Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana
od: Abraham Rexford Oduro, et al.
Izdano: (2019-01-01)

Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections
od: Junjie Ding, et al.
Izdano: (2024-11-01)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
od: Issaka Zongo, et al.
Izdano: (2014-01-01)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
od: Zongo, I, et al.
Izdano: (2014)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
od: Adam, I, et al.
Izdano: (2012)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
od: Tarning, J, et al.
Izdano: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
od: Adam, I, et al.
Izdano: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
od: Tarning, J, et al.
Izdano: (2012)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
od: Tarning, J, et al.
Izdano: (2007)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
od: Tarning, J, et al.
Izdano: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
od: Tarning, J, et al.
Izdano: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
od: Rijken, M, et al.
Izdano: (2011)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
od: Tarning, J, et al.
Izdano: (2014)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
od: Ashley, E, et al.
Izdano: (2010)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
od: Ashley, E, et al.
Izdano: (2010)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
od: Ashenafi Assefa, et al.
Izdano: (2022-12-01)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
od: Ashenaf Assefa, et al.
Izdano: (2023-04-01)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
od: Hoglund, R, et al.
Izdano: (2012)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
od: Chotsiri, P, et al.
Izdano: (2017)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
od: Hoglund Richard M, et al.
Izdano: (2012-11-01)

An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
od: Seth Owusu-Agyei, et al.
Izdano: (2008-06-01)

Quantification of the antimalarial piperaquine in plasma.
od: Tarning, J, et al.
Izdano: (2008)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
od: Mytton, O, et al.
Izdano: (2007)

Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana
od: Benjamin Abuaku, et al.
Izdano: (2023-01-01)

Semimechanistic pharmacokinetic and pharmacodynamic modeling of piperaquine in a volunteer infection study with Plasmodium falciparum blood-stage malaria
od: Wattanakul, T, et al.
Izdano: (2021)

Safety, pharmacokinetics, and mosquito‐lethal effects of ivermectin in combination with dihydroartemisinin‐piperaquine and primaquine in healthy adult Thai subjects
od: Kobylinski, KC, et al.
Izdano: (2019)

Pitfalls in estimating piperaquine elimination.
od: Tarning, J, et al.
Izdano: (2005)

Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria
od: Saito, M, et al.
Izdano: (2024)

Efficacy and Safety of Artemisinin-Piperaquine for the Treatment of Uncomplicated Malaria: A Systematic Review
od: Qi Wang, et al.
Izdano: (2020-09-01)

Efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria in Papua New Guinea
od: Livingstone Tavul, et al.
Izdano: (2018-10-01)

Brugada syndrome precipitated by uncomplicated malaria treated with dihydroartemisinin piperaquine: a case report
od: Muzakkir Amir, et al.
Izdano: (2024-09-01)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
od: Hadjar Siswantoro, et al.
Izdano: (2015-01-01)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
od: Hadjar Siswantoro, et al.
Izdano: (2015-01-01)

Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
od: Hanboonkunupakarn, B, et al.
Izdano: (2014)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
od: Byakika-Kibwika, P, et al.
Izdano: (2019)

Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial
od: Sevene, E, et al.
Izdano: (2019)

Treatment of uncomplicated and severe malaria during pregnancy
od: D’Alessandro, U, et al.
Izdano: (2018)

Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria
od: Thomas A. Anyorigiya, et al.
Izdano: (2021-01-01)